• Users Online: 466
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2021  |  Volume : 4  |  Issue : 2  |  Page : 45-50

Adjuvant botulinum toxin for endoscopic management (preaponeurotic endoscopic repair) of severe diastasis recti


1 Member of the Argentine Association of Surgery, Member of the Argentine Association of Hernias, Member of the Hispano-American Society of Hernias, Member of the Salta Surgery Society, Staff Surgeon of the General Surgery Service, Maternal and Child Public Hospital, Salta, Argentine Republic
2 Hospital Español of Rosario, Santa Fe (Argentine Republic), Italian University Institute of Rosario, IUNIR, Salta, Argentine Republic
3 Member of the Spanish Association of Surgery, Member of the Hispano-American Society of Hernias, Head of the General Surgery Service, Abdominal Wall Sector, Vithas NISA 9 de Octubre Hospital, Valencia, Spain
4 Member of the Venezuelan Society of Surgery, Associate of the General Hospital of Almansa, Associate of the Specialized Abdominal Wall Consultation at the Vithas NISA 9 de Octubre Hospital, Valencia, Spain

Correspondence Address:
Dr. Derlin Marcio Juarez Muas
Maternal-Infant Public Hospital - Salta, Av. Sarmiento, 1301, Salta (Argentine Republic), Passage 1, Nº. 16. La Almudena Neighborhood, 4400, Salta
Argentine Republic
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijawhs.ijawhs_49_20

Get Permissions

INTRODUCTION: Diastasis recti (DR) associated with midline hernias is common. Big size DR represents a clinical and cosmetic problem. Its repair is challenging, with intraoperative and postoperative risks. The adjuvant of botulinum toxin serotype A makes it possible to restoration of the linea alba by preaponeurotic endoscopic repair (REPA). METHODS: This was a retrospective study with prospective database. Between February 2019 and July 2020, six women were operated, with a mean age of 39 years and a diagnosis of DR >80 mm, with a body mass index of 27. All patients were infiltrated with 50 UR of botulinum toxin serotype A on each side, 30 days before the surgery. RESULTS: The intraoperative diagnosis of DR was 87.5 mm average, associated with midline hernias in 100%, with a mean transverse diameter of 24 mm (10–60 mm) Anatomical restoration of the linea alba was performed with a slow absorbable barbed suture. The wall was reinforced with 100% macroporous polypropylene mesh, with 83.3% atraumatic fixation and 16.6% absorbable traumatic fixation. The surgical time was 94 ± 15 min. Postoperative pain was 2/10 ± 1 according to the Visual Analog Scale, allowing a hospital stay of 18 ± 4 h. Return to work 18 ± 3 days. The mean follow-up was 9 (2–18) months by the clinical and ultrasound examination in 100%, without complications or recurrences. CONCLUSIONS: The application of botulinum toxin serotype A associated with endoscopic repair (REPA) allowed solving the big size DR and midline hernias with suture of the rectus sheath with less tension, associated with a reinforcement prosthesis, allowing a reduced hospitalization with a low level of postoperative pain, avoiding muscle release incisions, which are irreversible and not exempt from morbidity, added to the proven benefits of endoscopic access.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2733    
    Printed6    
    Emailed0    
    PDF Downloaded135    
    Comments [Add]    

Recommend this journal